Awareness, treatment, and control of vascular risk factors in African Americans with stroke

Neurology

Volumn 60, Issue 1, 2003, Pages 64-68

  Ruland, S ^a   Raman, R ^a   Chaturvedi, S ^a   Leurgans, S ^a   Gorelick, P B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE;

ADULT; AGED; ANAMNESIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STROKE;

EID: 0037435509     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.60.1.64     Document Type: Article

References (29)

1. American Heart Association. Heart and stroke statistical update 1999. Dallas: American Heart Association, 1998.
2. Gorelick PB. Stroke prevention. Arch Neurol 1995;52:347-355.
3. Harris MI, Hadden WC, Knowler WC, et al. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 1987;36:523-534.
4. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the U.S. adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-313.
5. Qureshi AI, Suri MFK, Guterman LR, et al. Ineffective secondary prevention in survivors of cardiovascular events in the U.S. population: Report from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2001;161:1621-1628.
6. Lynch G, Leurgans S, Raman R, et al. A comparison of stroke risk factors in patients enrolled in stroke prevention trials. J Natl Med Assoc 2001;93:79-86.
7. The Fifth Report of the Joint National Committee on Hypertension (JNC V). Arch Intern Med 1993;153:154-183.
8. American Diabetes Association. Clinical practice recommendations 1997. Diabetes Care 1997;20(suppl 1):S1-S70.
9. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015-3023.
10. Sacco RL, Shi T, Zamanillo MC, et al. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology 1994;44:626-634.
11. Bruno A, Biller J, Adams HP Jr, et al. Acute blood glucose level and outcome from ischemic stroke. Neurology 1999;52:280-284.
12. Chalmers J. Global impact of stroke. Heart Dis 2000;2:S13-S17.
13. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-1041.
14. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult U.S. population: data from the Health Examination Surveys, 1960-1991. Hypertension 1995;26:60-69.
15. Bone LR, Hill MN, Stallings R, et al. Community health survey in an urban African-American neighborhood: distribution and correlates of elevated blood pressure. Ethnic Dis 2000;10:87-95.
16. Freeman V, Rotimi C, Cooper R. Hypertension prevalence, awareness, treatment, and control among African Americans in the 1990s: estimates from the Maywood Cardiovascular Survey. Am J Prev Med 1996;12:177-185.
17. Kernan WN, Viscoli CM, Brass LM, et al. Blood pressure exceeding national guidelines among women after stroke. Stroke 2000;31:415-419.
18. Joseph LN, Babikian VL, Allen NC, et al. Risk factor modification in stroke prevention: the experience of a stroke clinic. Stroke 1999;30:16-20.
19. Nieto FJ, Alonso J, Chambless LE, et al. Population awareness and control of hypertension and hypercholesterolemia: the Atherosclerosis Risk in Communities Study. Arch Intern Med 1995;155:677-684.
20. Gorelick PB, Mazzone T. Plasma lipids and stroke. J Cardiovasc Risk 1999;6:217-221.
21. Gorelick PB, Schneck MJ, Berglund EJ, et al. Status of lipids as a risk factor for stroke. Neuroepidemiology 1997;16:107-115.
22. Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL). Stroke 2001;32:5890. Abstract.
23. Wolf PA, Clagett GP, Easton JD, et al. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 1999;30:1991-1994.
24. Sacco RL, Benson RT, Kargman MS, et al. High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA 2001;285:2729-2735.
25. Szklo M, Chambless LE, Folsom AR, et al. Trends in plasma cholesterol levels in the Atherosclerosis Risk in Communities (ARIC) study. Prev Med 2000;30:252-259.
26. Sempos CH, Cleeman JI, Carroll MD, et al. Prevalence of high blood cholesterol among U.S. adults: an update based on guidelines from the Second Report of the National Cholesterol Education Program Adult Treatment Panel. JAMA 1993;269:3009-3014.
27. Pieper RM, Arnett DK, McGovern PG, et al. Trends in cholesterol knowledge and screening and hypercholesterolemia awareness and treatment, 1980-1992. Arch Intern Med 1997;157:2326-2332.
28. The Sixth Report of the Joint National Committee on Hypertension (JNC VI). Arch Intern Med 1997;157:2413-2446.
29. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.